Which closed-end funds own Avalo Therapeutics Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $4.9M. Security type: common equity. Country: United States. CUSIP 05338F306 · ISIN US05338F3064 · ticker AVTX.
Holdings are historical filings (report dates May 29, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.35% | $2.4M | 129,858 sh | $690M | 3.4% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.18% | $2M | 108,171 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.09% | $499K | 27,026 sh | $573M | 2.8% discount | Jun 30, 2026 |
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.00% | $16 | 1 sh | $631M | 12.7% discount | May 29, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: AVALO THERAPEUTICS INC.
Issuer-level search for “AVTX” → · Compare two funds’ portfolios →